E-nitiate Biopharmaceuticals (hangzhou) Co., Ltd.

This study tests an experimental tablet called QY201 for adults with moderate to severe atopic dermatitis (eczema). About 460 participants will take either QY201 or a placebo daily for 16 weeks. The goal is to see if the drug can significantly clear skin and reduce itch, with a f…